Silverback Therapeutics shares owned by Credit Suisse
Quarter-by-quarter ownership of Silverback Therapeutics (SPRY) shares owned by Credit Suisse
from 13F filings
Historical chart of Credit Suisse investment in Silverback Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Silverback Therapeutics held by Credit Suisse consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Silverback Therapeutics by Credit Suisse
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-03-31 | $302k | 30k | 10.22 |
| 2023-12-31 | $162k | 30k | 5.48 |
| 2023-09-30 | $126k | 33k | 3.78 |
| 2023-06-30 | $214k | 32k | 6.70 |
| 2022-06-30 | $0 | 11 | 0.00 |
| 2021-06-30 | $232k | 7.3k | 31.82 |